Vimarsana
Biggest News Aggregation in the World

Expert Consensus Decision Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expert Consensus Decision Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expert Consensus Decision Pathway Today - Breaking & Trending Today

New ACC Guidance on Heart Failure With Preserved EF - Vimarsana News

New ACC Guidance on Heart Failure With Preserved EF

The Expert Consensus Decision Pathway offers a framework for diagnosis, clinical decision-making, management of comorbidities, and implementation of appropriate therapy.

ACC Issues Expert Consensus Decision Pathway on Cardiac Amyloidosis - Vimarsana News

ACC Issues Expert Consensus Decision Pathway on Cardiac Amyloidosis

The American College of Cardiology (ACC) has published its “2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis” in the Journal of the American College of Cardiology.

Evolocumab's LDL Lowering Surpassed Inclisiran's in ORION-3 - Vimarsana News

Evolocumab's LDL Lowering Surpassed Inclisiran's in ORION-3

Results from a crossover subgroup of 92 patients in ORION-3 documented evolocumab's greater LDL-lowering efficacy compared with inclisiran.

AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022 - Vimarsana News

AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022

Very low LDL-C Levels Data Reinforces Long-Term Efficacy and Consistent Safety Profile of Repatha Observed in FOURIER-OLE THOUSAND OAKS, Calif., N...

ACC Issues Guidance on Integrating ASCVD and Multimorbidity Care - Vimarsana News

ACC Issues Guidance on Integrating ASCVD and Multimorbidity Care

The new document offers a framework for pragmatic, patient-centered care for patients with ASCVD and multiple chronic conditions based on the patient's phase of life and individual circumstances.